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The surface M protein of group A streptococci is the principal virulence factor 
of these organisms. Streptococci lacking M protein are efficiently opsonized by 
the alternate complement pathway (1, 2) and in consequence are rapidly ingested 
and  killed  by  host  leukocytes. Streptococci possessing  surface M  protein  are 
neither opsonized nor ingested unless antibody to the M protein is present (3). 
Two  hypotheses,  which  are  not  mutually  exclusive,  have  been  advanced  to 
explain  the  antiphagocytic properties  of M  protein:  it  may be  toxic  to  the 
phagocyte in some way; or it may prevent opsonization of the streptococcal cells. 
The first possibility has not been investigated in detail. Crude, hot-acid extracts 
of M protein are toxic to polymorphonuclear leukocytes, but this appears to be 
due to the formation of antigen-antibody complexes involving non-type-specific 
antigens, rather than to a  direct toxic effect of the M  protein (4).  M  protein 
could nonetheless be toxic in the high concentrations prevailing at the surface 
of a streptococcal cell at its point of attachment to a phagocyte. Recently, Manjula 
and Fischetti (5) have speculated that  M  protein,  which has certain structural 
homologies to a-tropomyosin, might disable the phagocyte by interfering with 
its contractile proteins. 
The  second  possibility--that  M  protein  interferes  with  opsonization--has 
extensive experimental support.  When suspended in fresh serum, streptococci 
lacking M protein are opsonized by complement via the alternate pathway, which 
must be intact for phagocytosis to occur (2).  Streptococci possessing M protein 
activate this  pathway less  efficiently (1,  6). Jacks-Weis and her colleagues (6) 
noted that although M-positive streptococcal cells did activate complement and 
bind it (C3) on their surface, the bound C3 was distributed unevenly as shown 
by immunofluorescence microscopy. They suggested that  this patchiness pre- 
vented the smooth operation of the "zipper" mechanism of internalization pro- 
posed by Griffin et al. (7). 
In a  previous report, we showed that virulent M-rich streptococci, although 
partially resistant to opsonization when suspended in nonimmune human serum, 
were  completely resistant  when  suspended  in  plasma  (8).  The  opsonization- 
inhibiting activity of plasma was found to reside in fibrinogen: purified fibrinogen 
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added to streptococci and phagocytes suspended in serum suppressed opsoniza- 
tion in a  dose-dependent manner. These observations suggested that a  reaction 
first reported almost 25 years ago, the precipitation of fibrinogen by extracts of 
M  protein (9,  10),  might be relevant to the known antiphagocytic functions of 
this  molecule.  We  found  that  fibrinogen  bound  to  the  fibrillae  of type  24 
streptococcal cells and thereby prevented binding of complement (C3) to the cell 
surface (8,  11). 
In the previous study, we investigated the influence of fibrinogen on nonim- 
mune  opsonization  of streptococci  by  complement.  In  the  present  study,  we 
investigated the influence of fibrinogen on antibody-mediated opsonization of 
these  organisms.  We  present  data  to  suggest  that  purifed  M  proteins  elicit 
antibodies directed toward both fibrinogen-binding and fibrinogen-nonbinding 
regions of the M  protein molecule, and that certain cross-reactions between M 
protein serotypes involve fibrinogen binding sites. We suggest that some of the 
known structural and antigenic similarities among M proteins of different sero- 
types may be related to their ability to bind fibrinogen, which is in part the basis 
for their antiopsonic function. 
Materials and Methods 
Streptococci.  Group A streptococci of types 5 (Manfredo), 6 ($43),  and 24 (Vaughn) 
were blood-passed to achieve a high level of resistance to phagocytosis (3). Cultures were 
stored at -80°C and subsequently on blood agar plates at 4°C. Colonies were grown 
overnight at 37°C in Todd-Hewitt broth (Difco Laboratories, Detroit, MI) supplemented 
with 20%  normal rabbit  serum  (Gibco  Laboratories, Grand Island,  NY),  subcultured 
1:100 in the same medium, and grown to early log phase. Organisms were harvested by 
centrifugation, exposed to ultraviolet light for 3 min, washed in phosphate-buffered saline 
(PBS) 1 (0.15  M NaCI-0.02  M phosphate, pH 7.2-7.4), and resuspended in PBS to the 
desired optical density. 
Antisera to Streptococcal  M Proteins.  Large polypeptide fragments of M proteins of types 
5,  6,  19,  and  24--"pep  M  proteins"--were  purified  from pepsin  extracts  of whole 
organisms (12). Rabbits were immunized intracutaneously with 100 #g of pep M protein 
emulsified incomplete Freund's adjuvant and boosted 1 wk later with an additional 100 
~tg dose in incomplete Freund's adjuvant as previously described (12).  Antisera were 
inactivated by heating at 56°C for 30 min. Each antiserum was tested in an enzyme-linked 
immunosorbent assay (ELISA) for reaction with pep M proteins of types 5, 6, 19, and 24, 
using  a  semi-automated  EIA  system  (PR-50,  Gilford  Instrument  Laboratories,  Inc., 
Oberlin, OH) (13). 
Human Blood and Blood Components.  Normal volunteers were selected who lacked pre- 
existing antibody to types 5, 6, and 24 streptococci as determined by ELISA (reciprocal 
titers -<200) and by opsonophagocytic tests (see  below)  using whole blood and blood 
reconstituted from serum or plasma and cells. Plasma and blood cells were obtained from 
whole blood to which heparin 5 U/ml (~-8 U/ml plasma) was added (heparin from hog 
intestine, Eli Lilly and Co., Indianapolis, IN). Erythrocytes and buffy coat were washed 
three times in a total of 100 ml Hanks' balanced salt solution. Serum was collected so as 
to minimize the formation of fibrin(ogen) degradation products and the loss of labile 
opsonins. Blood was drawn without stasis and allowed to clot completely during centrif- 
ugation at room temperature; serum was separated promptly and iced. The sera contained 
1  Abbreviations used in this paper:  BSA,  bovine serum albumin; cfu, colony-forming  units; ELISA, 
enzyme-linked  immunosorbent  assay; FHP, fresh heparinized  (human)  plasma; FHS, fresh heparinized 
(human) serum; pep M, purified pepsin extract of M protein; PMN, neutrophilic polymorphonuclear 
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<1  nM fibrinogen equivalent by the Thrombo-Wellcotest latex agglutination test (Bur- 
roughs Wellcome Co., Greenville, NC). Heparin was added to sera at 8 U/ml. 
Opsonophagocytic Tests.  In the  variation  of the  standard  opsonophagocytic test  (12) 
employed here,  107 colony-forming units (cfu) of streptococci in 20 #1 PBS were prein- 
cubated for 15 min at 37 °C with 100 #1 diluted antiserum or control plus 100 #1 fibrinogen 
at the desired concentration, brought to room temperature, and then mixed with 200 #1 
fresh heparinized  serum  (FHS) and  150  #1  washed blood cells.  In some experiments, 
organisms were preincubated at 37°C  with antiserum and either fresh serum or fresh 
plasma before addition of blood cells.  Test mixtures were rotated at  10 rpm end-over- 
end at 37°C. Small samples (20 #1) were removed at 15-min intervals, smeared on glass 
slides, stained with Wright's stain, and examined under oil immersion. One or two hundred 
PMN were counted, noting the percentage with associated bacteria (percent association) 
without attempting to distinguish attached from ingested organisms. All values shown in 
the  text  were  obtained  at  30  min  of incubation.  The  procedure  differed  from that 
previously reported (8) in that the entire buffy coat was used instead of isolated PMN, 
and the concentrations of PMN and streptococcal cells in the test mixtures were both 
reduced two- to threefold so that the baseline percent association (i.e., without antibody) 
was <40%, and the maximum percent association was <80%. 
Bactericidal Test.  The bactericidal test was performed similarly to the opsonophagocytic 
test, except that the inoculum was reduced by dilution to <200 cfu and the incubation 
period was extended  to  3 h  (14).  50  ~! of a  log-phase culture  diluted  in Todd-Hewitt 
broth was added to a mixture of 50 #! normal or immune rabbit serum and 100 #1 human 
plasma or heparinized serum. After incubation at ambient temperature for 15 min, 200 
#1 washed blood cells and 150 #1 additional plasma or serum were added and the mixtures 
rotated for 3 h at 37°C. Surviving organisms were counted by the pour plate method. 
Fibrinogen.  Human flbrinogen (90% clottable, Grade L, KABI Diagnostica, Stockholm, 
Sweden)  was  dissolved  in  PBS  containing  1%  bovine  serum  albumin  (BSA)  (Sigma 
Chemical Co., St. Louis, MO) at a concentration of 10 #M, dialyzed against PBS to remove 
citrate, and stored at -20°C. 
Affinity Chromatography and Radiolabeling of  Anti-pep M5.  Pep M5 (10 rag) was covalently 
linked  by one-step carbodiimide coupling to  2.5 g  CH-Sepharose 4B  (Pharmacia  Fine 
Chemicals, Uppsala, Sweden) as previously described (14).  After the column was equili- 
brated with PBS, 0.5  ml of rabbit anti-pep M5 was applied and allowed to incubate for 
30  min  at  ambient  temperature.  The  column  was  then  washed  with  PBS  until  the 
ultraviolet  absorbance at  230  nm  of the  effluent  returned  to  baseline.  Anti-pep  M5 
antibodies were eluted with 0.2 M glycine-0.2 M NaC1, pH 2.8. The antibody-containing 
fractions were dialyzed against PBS and concentrated by membrane filtration (YM  10 
membrane, Amicon  Corp.,  Scientific  Systems Division,  Lexington,  MA).  The  protein 
concentration of the product was 23 #g/ml as estimated by the method of Waddell (15). 
Radioiodination of 3 #g of protein was carried out using a  commercial lactoperoxidase 
kit (NEZ-151, New England Nuclear, Boston, MA). Specific activity of the product was 
0.2 Ci/g protein. 
Binding of Radiolabeled Anti-pep M5 to Streptococcal Cells.  Incubation mixtures consisted 
of 108 cfu UV-treated, log-phase streptococci, affinity-pmified antibody, and fibrinogen 
in a total volume of 200 #1 PBS containing 0.1% Tween-20. Incubations were carried out 
in  1.5  ml polypropylene tubes at ambient temperature for 45 rain. The mixtures were 
centrifuged at  15,600 g  for 2  min.  The pellets were washed three times in  PBS-0.1% 
Tween-20. Washed pellets were counted in a  gamma scintillation spectrometer (Model 
578, Packard Instrument Co., Downers Grove, IL). 
Results 
In a  previous study,  we demonstrated  that  fibrinogen in nonimmune plasma 
interfered with the complement-mediated opsonization of group A  streptococci 
by binding  to  the  M  protein  on  the  surface  of the  organisms.  In  the  present 
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mediated opsonization of M-rich streptococci was investigated. For these studies, 
we selected types 5,  6,  19,  and 24 streptococci and antisera raised in rabbits 
against the respective pep M proteins. Each of the antisera except anti-pep M24 
showed cross-reactions with other serotypes (Table I). The use of these anti-sera 
in the following studies enabled an evaluation of type-specific and cross-reactive 
epitopes in relation to fibrinogen-M protein interactions. 
Influence  of Fibrinogen on Opsonization by Homologous Anti-pep  M  Antisera.  The 
observation that association of type 24 streptococci with neutrophils is reduced 
in the presence of fibrinogen (8) was extended to the three other serotypes used 
in the present study. For example, type 6 streptococci were only partially resistant 
to uptake by leukocytes suspended in fresh serum but were completely resistant 
when suspended in fresh plasma (Fig.  1).  Addition of rabbit antiserum raised 
against purified homologous pep M6 promoted uptake both in serum and in 
plasma in  a  dose-related manner, and as  the antibody concentration was  in- 
creased, the difference in uptake between plasma and serum was abolished (Fig. 
1). Similar results were obtained with streptococci of types 5 (see Fig. 4),  19, and 
24 (data not shown). These results suggested that the homologous M antibodies 
either competed successfully with fibrinogen for common M  protein binding 
regions or recognized epitopes not encompassed by the fibrinogen binding site(s). 
To determine whether the antibodies reacted with fibrinogen binding or non- 
binding regions, a suboptimal concentration of homologous  antiserum was added 
with increasing concentrations of fibrinogen to a mixture of type 24 streptococci 
TABLE  I 
Cross-reacting Rabbit Antisera to Streptococcal Pep M Proteins 
Immunizing  Cross-react-  ELISA titers against: 
Serum  Ag*  ing Ag*  Immunizing  Cross-react- 
(M-type)  (M-type)  Ag*  ing Ag* 
8104  19  5  25,600  6,400 
7908  5  6  102,400  51,200 
7633  6  5  51,200  25,600 
* Ag, pep M protein antigen. 
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FIGURE  1.  Uptake of type 6 streptococci by PMN suspended in serum ((3) or plasma (O) to 
which anti-pep M6 in twofold increasing amounts was added.  Diluent (D/0, 1% bovine serum 
albumin in phosphate-buffered  saline. WttITNACK  ET  AL.  1205 
and  washed blood  cells  suspended  in  fresh  human  serum.  The  fibrinogen 
suppressed opsonization in a dose-related manner (Fig. 2). Suppression, however, 
was only partial, reaching a plateau at 0.12 #M of fibrinogen, the physiologic 
concentration of fibrinogen in plasma being -10 #M.  This finding suggested 
that there are antigenic sites on M protein that remain exposed and available for 
reaction with antibody even when fibrinogen has presumably saturated its bind- 
ing sites. At the higher concentrations of antibody, however, opsonization could 
be partly inhibited if the organisms were exposed to fibrinogen before addition 
of antibody (Fig. 3), suggesting that there are other sites on M protein for which 
fibrinogen and antibody compete. 
Influence  of Fibrinogen on Opsonization by M  Protein Cross-reactive Antisera.  Be- 
cause the preceding studies suggested a heterogeneity of opsonogenic M protein 
epitopes, some of which reside in fibrinogen binding regions of the molecule, we 
investigated the  possibility  that  epitopes shared among different  M  protein 
serotypes may reside in the fibrinogen binding region, reasoning that fibrinogen 
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FIGURE 2.  Uptake by PMN of type 24 streptococci in the presence of anti-pep M24 to which 
fibrinogen (Fgn) was added in threefold increasing concentrations up to 10 ttM. Also shown 
are experiments in which the streptococcal cells were exposed to fibrinogen for  10 min at 
room temperature before adding antibody (A). In the absence of antibody (No ab), fibrinogen 
(10 ttM) completely inhibited uptake. 
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FIGURE 3.  Uptake by PMN of type 24 streptococci opsonized with anti-pep M24 (A-24)  and 
either fresh heparinized plasma (FHP) or serum (FHS). At this concentration of antibody, 
uptake was equal in serum and in plasma. However, when the organisms were exposed to 
plasma before addition of antibody, partial inhibition of opsonization was obtained. 1206  FIBRINOGEN-BINDING  EPITOPES  OF  STREPTOCOCCAL  M  PROTEINS 
binding sites on different M proteins might be structurally and therefore anti- 
genically similar. Two cross-reactive antisera were selected because they exhib- 
ited  high  titers  of antibody  by  ELISA  against  heterologous  serotypes  of  M 
proteins, but had failed to opsonize the cross-reactive streptococci in the presence 
of fibrinogen in whole blood. One was an anti-pep M5 that cross-reacted with 
pep M6 and the other was an anti-pep M6 that cross-reacted with pep M5 (see 
Table I). A  third cross-reactive antiserum, an anti-pep M19 that cross-reacted 
with pep M5 (Table I), was selected at random from the laboratory files. 
First, type 5 streptococci were opsonized with serial twofold dilutions of each 
antiserum  in  the  presence  or  absence  of  5  /~M  fibrinogen  (Fig.  4).  In  the 
homologous system (Fig.  4A),  uptake of bacteria  by PMN  was  suppressed by 
fibrinogen only at submaximal antibody concentrations, as previously noted with 
type 6 organisms (see Fig. 1). In contrast, uptake in the presence of cross-reacting 
antisera was suppressed even at antiserum concentrations that promoted maximal 
uptake  in  the  absence  of  fibrinogen  (Fig.  4,  B  and  C);  in  the  presence  of 
fibrinogen, anti-pep M6 (Fig. 4 C) failed to promote uptake at any concentration 
of antiserum tested. Similarly, the anti-pep M5 serum opsonized type 6 strepto- 
cocci well in the absence of fibrinogen, with uptake approaching its maximum at 
an antiserum dilution of 1:256, whereas no opsonization could be obtained with 
undiluted antiserum in the presence of 5/LM fibrinogen (not shown). To confirm 
the ability of the type-specific and cross-reactive sera to promote killing of the 
streptococci,  bactericidal  tests  corresponding  to  the  opsonophagocytic  tests 
shown in Fig. 4, A and C were performed (Table II). In the presence of anti-pep 
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FZGURE 4.  Uptake  by  PMN  of type  5  streptococci  opsonized  with  twofold  dilutions  of 
homologous anti-pep M5 (A), cross-reacting anti-pep M19 (B), or cross-reacting anti-pep M6 
(C) antisera in the presence (0) or absence (O) of 5 pM fibrinogen. Control, 1% bovine serum 
albumin in phosphate-buffered saline (antiserum diluent). 
TABLE  II 
Bactericidal Test of Type 5 Streptococci with Homologous and Heterologous Anti-pep M Sera 
Colonies surviving a 3-h incubation in the presence of: 
Inoculum  Normal rabbit serum  Anti-pep M5 (homolo-  Anti-pep M6 (heterolo- 
and:  gous) and:  gous) and: 
Plasma  Serum  Plasma  Serum  Plasma  Serum 
100  7,200  891  0  0  735  0 
25  367  129  0  0  75  0 WHITNACK  ET  AL.  1207 
M5,  leukocytes sterilized  homologous type  5  organisms  suspended either  in 
serum or in plasma. In the presence of the cross-reacting anti-pep M6, type 5 
organisms were sterilized only in serum, although partial reduction of growth 
was obtained in plasma. 
Next, streptococci of types 5 and 6 were opsonized with submaximal concen- 
trations of anti-pep M5 in the presence of increasing concentrations of fibrinogen 
(Fig.  5). The behavior of the homologous system was similar to that previously 
found for the type 24 system (see Fig. 2), in that partial inhibition was obtained 
that could not be increased by further addition of fibrinogen. In contrast, uptake 
of the heterologous type  6  organisms was completely inhibited at  the  lowest 
concentration of fibrinogen tested (Fig.  5). Similarly, uptake of type five organ- 
isms opsonized with anti-pep M6 was completely suppressed by 0.1 #M fibrinogen 
(not  shown).  These  results  suggested that  most  of the  opsonic cross-reactive 
antibodies in these two sera were directed against epitopes lying within or closely 
adjacent to fibrinogen binding regions of the respective M proteins. 
Inhibition  of the Binding of Type-specific and Cross-reactive M  Antibodies  to M-rich 
Streptococci  by  Fibrinogen.  Having  established  that  fibrinogen  interferes  with 
opsonization mediated by antibodies against M protein, especially by those against 
cross-reactive epitopes,  we  next  investigated the  effect of fibrinogen on  the 
binding of radiolabeled type-specific and cross-reactive antibodies to M protein 
on the surfaces of intact streptococci. For this purpose the anti-pep M5 serum 
was subjected to affinity chromatography on a  column of Sepharose to which 
pep M5 was covalently linked (see Materials and Methods). The purified antibody 
preparation had ELISA titers of 1:6,400 against pep M5 and 1:800 against pep 
M6. The effect of fibrinogen on uptake by PMN of types 5 and 6 streptococci 
opsonized with the purified antibodies was compared to its effect on the binding 
of radioiodinated antibodies to the same organisms. The quantity of antibody 
was adjusted in each case so that the control values of binding and uptake for 
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FIGURE ,5.  Uptake by PMN of type 5 (O) and type 6 (O) streptococci opsonized with anti- 
pep M5 in the presence of increasing concentrations of fibrinogen. The antiserum was diluted 
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heterologous (type 6) organisms were at least as great as those for homologous 
(type 5) organisms. Opsonization of types 5 and 6  streptococci by the affinity- 
purified  radioactive antibody  (Fig.  6A)  was  similar to  that  obtained  with  the 
original serum (compare Fig. 5).  Fibrinogen inhibited binding of antibody both 
to the homologous and  to the heterologous organisms in a  manner generally 
parallel  to its inhibition of opsonization, except that the percent inhibition of 
uptake  at  any  given  fibrinogen  concentration  was  greater  than  the  percent 
inhibition of binding (Fig.  6B).  This  difference  may be  due  to  inhibition  of 
fibrinogen of direct (nonimmune) complement-mediated opsonization (8) which, 
at  the  low  concentrations  of antibody  used  in  these  experiments,  may  be  a 
significant component of the total opsonization. 
Discussion 
This study was undertaken with three purposes in mind: (a) to determine the 
effect of fibrinogen on opsonization of streptococci by antibody to homologous 
M protein; (b) to see whether antibodies are formed against M protein determi- 
nants  masked  by  fibrinogen  in  vivo;  and  if  so  (c)  to  see  whether  any  such 
determinants are shared between M protein serotypes. 
Addition of sufficient quantitites of antibody to homologous M protein had 
much the same effect on uptake by PMN as removal of M protein from the cell 
surface by trypsin (8): uptake increased substantially regardless of the presence 
of fibrinogen in the test mixture, and the difference between uptake in serum 
and in plasma was eliminated. This result  is not surprising since opsonization 
and phagocytosis of group A streptococci in the whole blood of immune persons 
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FIGURE 6.  Inhibition by fibrinogen of the interaction of anti-pep M5 antibodies with type 5 
(@) and type 6  (O) streptococcal cells.  (A) Uptake by PMN of streptococci  opsonized with 
affinity-purified anti-pep M5  antibodies diluted  1:42 for type 5,  1:11  for  type 6.  Gontrol 
(100%) =  45% phagocytosis for type 5, 55% for type 6. (B) Binding of l~SI-labeled affinity- 
purified anti-pep M5 antibodies to streptococcal cells. Type 5 cells were treated with labeled 
antibody (1:92) mixed with unlabeled antibody (1:10). Type 6 cells were treated with labeled 
antibody alone (1:13). Control binding (100%) = 2,724 cpm for type 5; 5,055 cpm for type 6. WHITNACK  ET  AL.  1209 
has been repeatedly documented (3). Opsonization by low levels of homologous 
antibody could be partly reduced in the presence of fibrinogen, but not beyond 
a  certain  point,  from which we conclude that  some M  protein determinants 
remain exposed after binding of fibrinogen. Opsonization in the presence of 
fibrinogen may therefore be accomplished in part by antibodies against these 
exposed determinants. 
In the absence of fibrinogen, there at  least  two  ways  that  opsonization of 
streptococci may be accomplished: activation and binding of complement  directly 
by  cell-surface  structures  (1,  2,  6,  8),  and  binding of anti-M  antibody  with 
subsequent activation and binding of complement (3). Fibrinogen clearly inhibits 
the first of these (8) and therefore a reduction in bacterial uptake by PMN when 
fibrinogen is added to immune serum in the presence of complement would not 
necessarily mean that fibrinogen interferes with immune opsonization. However, 
we found that at the higher ranges of antiserum concentration, uptake could be 
partly reduced by pretreatment with fibrinogen, whereas co-treatment had no 
effect. Apparently certain determinants on M protein that are normally masked 
by fibrinogen may be occupied by antibody when present in sufficiently high 
concentration.  This  conclusion  is  supported  by  the  finding  that  fibrinogen 
inhibits the binding of affinity-purified radiolabeled antibodies to streptococcal 
cells.  Formation of antibodies against determinants normally masked by fibrin- 
ogen could occur if the pep M proteins, because they are administered intracu- 
taneously in a mineral oil emulsion, did not form complexes with fibrinogen in 
vivo; or if pep M-fibrinogen complexes were degraded in the course of antigen 
processing so as to expose fibrinogen binding sites. Whether such antibodies are 
formed during a natural infection is at present unknown. 
Although immunity to streptococcal infections is generally type-specific, cross- 
reactions between M  serotypes have been encountered by many investigators 
beginning with the earliest studies of streptococcal immunity (16). Some of these 
cross-reactions are protective (opsonic), but many others have been detected only 
in other assays such as immunoprecipitation, hemagglutination, or complement- 
fixation tests using extracted M proteins (16,  17). With the development of new 
methods for purifying M proteins, it has been possible to show definitively that 
there are  both  opsonogenic and  nonopsonogenic determinants shared  by  M 
proteins of different serotypes (18,  19).  M  proteins of types 6  and  14,  which 
share antigenic determinants, yield similar tryptic peptide maps (20).  Further- 
more, elucidation of the primary structure of types 5, 6, and 24 M proteins has 
revealed significant sequence homologies among the three types (5,  21).  The 
primary structures predict regions of a-helical coiled-coil conformation for each 
of these M proteins (5). This prediction has been confirmed for type 6 M protein 
(22).  Thus, M proteins appear to have similar secondary and tertiary structures 
as well. 
The occurrence of structural similarities and shared antigenic determinants 
among M proteins of different serotypes raises the possibility that some of these 
common features may pertain to the ability of M proteins to bind fibrinogen, 
and suggests an explanation for the failure of some anti-M antibodies to opsonize 
streptococci in vivo or in whole blood.  We found that opsonization by three 
cross-reactive anti-pep M sera was strongly inhibited or abolished by fibrinogen 1210  FIBRINOGEN-BINDING EPITOPES  OF  STREPTOCOCCAL  M  PROTEINS 
at physiologic concentration compared with opsonization by homologous anti- 
sera. Two of the sera (anti-pep M5 and anti-pep M6) are examples of apparently 
nonopsonic or poorly opsonic cross-reactive antibodies that become opsonic in 
vitro when fibrinogen is omitted from the test mixtures. The significance of such 
antibodies in vivo remains to be investigated. 
These studies do not constitute a survey of M protein cross-reactions. There 
is no reason to think that all cross-reactions involve fibrinogen-binding regions 
of M  protein, and indeed it would be surprising if this were found to be true. 
Nor is there reason to believe that a single fibrinogen binding epitope is shared 
by all  M  protein serotypes; none of the three cross-reactive sera reacted with 
type 24 M protein. These reservations notwithstanding, our data are consistent 
with the idea that fibrinogen binding regions of M  proteins may have limited 
serologic  specificity.  Such  an  interpretation  is  attractive  from  the  teleologic 
standpoint, since one might reasonably expect that in the evolution of M proteins 
from one serotype to another, fibrinogen binding sites would be conserved to 
maintain  the protective  function of M  protein,  while exposed sites would be 
varied to escape immune recognition. Further studies with reagents of greater 
specificity--monoclonal anti-M antibodies and peptide fragments of M protein 
and fibrinogen--may clarify these issues. 
Summary 
The influence of fibrinogen on the opsonization of Group A  streptococci by 
type-specific  and  cross-reactive  anti-M  protein  antisera  was  investigated.  As 
previously reported for type 24 streptococci, fibrinogen inhibited the comple- 
ment-mediated opsonization of types  5,  6,  and  19  organisms.  Rabbit  antisera 
against  large  peptide  fragments  of purified  homologous  M  proteins  (pep  M 
proteins)  overcame the  anti-opsonic effect of fibrinogen  in a  dose-dependent 
manner.  In the presence of optimal amounts of antibody, bacterial  uptake by 
PMN  was equal  in serum and plasma, and greater than could be obtained in 
serum in the absence of antibody.  Polyclonal rabbit anti-pep M  sera contained 
antibodies directed against fibrinogen-binding as well as fibrinogen-nonbinding 
sites or regions of the M protein molecule. Three cross-reactive anti-pep M sera 
included antibodies directed against fibrinogen binding sites or regions of the 
cross-reacting  M  proteins.  In  the  two  sera  studied in  detail,  these antibodies 
accounted for a  large part of the cross-reacting anti-M antibody present in the 
sera. We suggest that fibrinogen binding sites on different serotypes of M protein 
may be structurally and therefore antigenically similar. Conservation of fibrino- 
gen binding sites on M proteins may be related to their protective anti-opsonic 
function. 
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